(Q24796232)

18 December 2019

proto-oncogene protein

1 reference

biomedical investigative technique

2 August 2019

1 reference

19 September 2019

1 reference

22 October 2019

1 reference

20 November 2019

1 reference

10 December 2019

1 reference

18 December 2019

1 reference

3 December 2020

Robert L Sutherland

1

0 references

Elizabeth A Musgrove

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2002

0 references

30 November 2001

13 references

13 March 2019

3 April 2019

20 June 2019

17 June 2019

2 August 2019

19 September 2019

22 October 2019

20 November 2019

10 December 2019

18 December 2019

3 December 2020

3 July 2022

27 January 2024

Breast Cancer Research

13 references

13 March 2019

3 April 2019

20 June 2019

17 June 2019

2 August 2019

19 September 2019

22 October 2019

20 November 2019

10 December 2019

18 December 2019

3 December 2020

3 July 2022

27 January 2024

4

0 references

issue

1

0 references

page(s)

14-7

0 references

cites work

Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Chromosome 11q13 abnormalities in human breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

A novel cyclin encoded by a bcl1-linked candidate oncogene

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Blocking oncogenic Ras signaling for cancer therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Specific protection against breast cancers by cyclin D1 ablation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Role of erbB2 in breast cancer chemosensitivity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154565

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR411

Cyclin D1 protein expression and function in human breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR411

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

21 January 2018

1 reference

12 December 2020

Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast

1 reference

12 December 2020

Expression and amplification of cyclin genes in human breast cancer

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining

1 reference

12 December 2020